Voyager Therapeutics, Inc.VYGRNASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank92
3Y CAGR+40.3%
5Y CAGR+5.6%
Studio
Year-over-Year Change

Net other income and expenses outside core operations

3Y CAGR
+40.3%/yr
vs +14.1%/yr prior
5Y CAGR
+5.6%/yr
Recent acceleration
Acceleration
+26.2pp
Accelerating
Percentile
P92
Near historical high
vs 5Y Ago
1.3x
Solid growth
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$12.27M-35.3%
2024$18.95M+61.6%
2023$11.72M+163.8%
2022$4.45M+83.6%
2021$2.42M-74.1%
2020$9.36M+15.8%
2019$8.08M+207.7%
2018$2.63M+125.5%
2017$1.17M+0.6%
2016$1.16M-